Horizon Pharma (HZNP) Reports In-Line Q1 EPS; Lifts FY15 Revenue Outlook
Get Alerts HZNP Hot Sheet
Join SI Premium – FREE
Horizon Pharma (NASDAQ: HZNP) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $113.1 million versus the consensus estimate of $104.2 million.
Horizon Pharma sees FY2015 revenue of $590-610 million, versus prior guidance of $450-475 million and the consensus of $538.8 million.
For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbus revenue rises, delivers 142 commercial aircraft in Q1
- Union Pacific (UNP) Tops Q1 EPS by 18c
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!